A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea

BACKGROUND: There are few pharmacologic options to reduce erythema and flushing in patients with recalcitrant erythematotelangiectatic rosacea (ETR). We previously reported two cases of refractory flushing and erythema of rosacea that were successfully treated with intradermal botulinum toxin inject...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Dermatol
Autors principals: Park, Kui Young, Kwon, Hyun Jung, Kim, Jae Min, Jeong, Guk Jin, Kim, Beom Joon, Seo, Seong Jun, Kim, Myeong Nam
Format: Artigo
Idioma:Inglês
Publicat: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992459/
https://ncbi.nlm.nih.gov/pubmed/33911508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2018.30.6.688
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars